Paul Tudor Jones Chroma Dex Corp. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 159,548 shares of CDXC stock, worth $979,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159,548
Previous 371,798
57.09%
Holding current value
$979,624
Previous $2.57 Million
61.83%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
167Shares Held
27.9MCall Options Held
152KPut Options Held
178K-
Vanguard Group Inc Valley Forge, PA3.92MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.6MShares$9.84 Million0.01% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.58MShares$9.71 Million8.91% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...